Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan® | MicrobiomeTrials← Back to trialsNCT06298409
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-02-15Est. Completion: 2026-02-28
Enrollment target: 34 participants Locations- Silicon Valley Gastroenterology, Mountain View, California, United States
Other microbiome trials you might be interested in
Anal Incontinence
The objectives of this work are: 1/to estimate the frequency of a positive glucose breath test in favour of a small inte…
Rouen, FranceCompleted Jun 2015
Inappropriate PrescribingReflux DiseaseProton Pump Inhibitors
The DROPIT Trial is an interventional, open-labelled, cluster-randomized controlled trial conducted in the Swiss primary…
Bern, SwitzerlandEst. completion Apr 30, 2027
Recruiting
Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea (IBS-D)Repetitive Transcranial Magnetic Stimulation (rTMS)Chronic DiarrheaIntestinal Flora
Objectives: This study aims to evaluate the clinical efficacy and safety of repetitive transcranial magnetic stimulation…
Suzhou, ChinaEst. completion Jul 1, 2026